Polymorphisms in CYP3A & ABCB1 are not associated with cyclosporine pharmacokinetics nor with clinical endpoints after renaltransplantation

Rachida Bouamar; Dennis Hesselink; Ron van Schaik; Willem Weimar; I Macphee; J de Fijter; Teun Gelder

Polymorphisms in CYP3A & ABCB1 are not associated with cyclosporine pharmacokinetics nor with clinical endpoints after renaltransplantation

Rachida Bouamar, Dennis Hesselink, Ron van Schaik, Willem Weimar, I Macphee, J de Fijter, Teun Gelder

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	480-480
Number of pages	1
Journal	Therapeutic Drug Monitoring
Volume	33
Issue number	4
Publication status	Published - 2011

Cite this

@article{d769cd0041b94868b2d33c2ffbb6b230,

title = "Polymorphisms in CYP3A & ABCB1 are not associated with cyclosporine pharmacokinetics nor with clinical endpoints after renaltransplantation",

author = "Rachida Bouamar and Dennis Hesselink and {van Schaik}, Ron and Willem Weimar and I Macphee and {de Fijter}, J and Teun Gelder",

year = "2011",

language = "Undefined/Unknown",

volume = "33",

pages = "480--480",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

TY - JOUR

T1 - Polymorphisms in CYP3A & ABCB1 are not associated with cyclosporine pharmacokinetics nor with clinical endpoints after renaltransplantation

AU - Bouamar, Rachida

AU - Hesselink, Dennis

AU - van Schaik, Ron

AU - Weimar, Willem

AU - Macphee, I

AU - de Fijter, J

AU - Gelder, Teun

PY - 2011

Y1 - 2011

M3 - Article

SN - 0163-4356

VL - 33

SP - 480

EP - 480

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 4

ER -